Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Loyalty programs and increased collaboration will be key features of post-pandemic travel, says GlobalData

Price-conscious travelers may be lured by the reboot of loyalty programs across the tourism sector. Various travel companies are now repositioning loyalty programs as value-orientated, rather than solely price focused in post-pandemic travel as they seek to tap into individuals’ desires for budget experiences, says GlobalData, a leading data and analytics company. GlobalData’s survey found […]
Read more

CMOs reap the benefits of COVID-19 manufacturing and timescale demands, says GlobalData

The COVID-19 pandemic brought not just a more difficult business environment to operate in, but also opportunities for contract manufacturing organizations (CMOs), as even the largest biopharma companies require extra capacity to supply billions of doses. Due to compressed timelines and manufacturing scale challenges for COVID-19 vaccines and medicines, CMOs signed contract manufacturing service agreements […]
Read more

Mental health benefits will become increasingly valuable to insurers and employee benefit providers post-COVID-19, says GlobalData

The COVID-19 pandemic has opened up a wealth of opportunities for insurers and employee benefit providers to deliver mental health packages as prolonged lockdowns and periods of mental strain and stress, as well as financial concerns for some, have further raised the significance of mental health in the workplace, says GlobalData, a leading data and […]
Read more

Integra’s Q1 financials indicate rebound in neurosurgical procedures following significant delays in 2020, says GlobalData

Following the recent release of Q1 2021 financial information from Integra LifeSciences, Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “Integra reported a Q1 2021 neurosurgery growth of 2.3% and 5.4% when compared to Q1 2020 and Q1 2019, respectively. Compared with a 6.7% decrease in Q4 […]
Read more

Kraft Heinz’s emphasis on e-commerce for packaged foods saw successful financial quarter, says GlobalData

Following today’s news (April 29th) that Kraft Heinz has released its Q1 2021 financials, Ramsey Baghdadi, Consumer Analyst at GlobalData, a leading data and analytics company, offers his view: “The continued high-grade financial performance from Kraft Heinz in Q1 2021 was driven by its focus in e-commerce. The company’s achievement to out-perform its sales success […]
Read more

With over 28 million SVoD Subscribers in the UK in 2020, a joint venture with an SVOD player could broaden BT Sports’ audience significantly, says GlobalData

Following today’s news (29 April) that the UK’s BT Group is in talks on a deal regarding its sports division, with a view to potentially sell a stake or the entirety of the BT Sport division or consider a partnership or joint venture. The talks reportedly include media players like DAZN and Disney, tech hyperscaler […]
Read more

CureVac’s unique vaccine properties are key for mRNA vaccine delivery to developing nations, says GlobalData

As COVID-19 cases continue to soar in some countries, demand for Pfizer and Moderna’s vaccines is fast exceeding production capabilities, while restrictions placed on AstraZeneca and Johnson & Johnson’s adenovirus-based vaccines have placed additional pressures on global vaccine rollouts, particularly in Europe. CureVac’s expected entry into the COVID-19 vaccine market may provide a viable alternative […]
Read more

Ghana GRIDCo and CSquared partnership supports much needed expansion of the fiber network in Ghana, says GlobalData

Following the news that Ghana Grid Company (GRIDCo) and fiberco CSquared announced a partnership that allows CSquared to lease GRIDCo’s excess fiber lines; Madison Galati, Technology Market Data & Intelligence Analyst at GlobalData, a leading data and analytics company, offers her view on the partnership: “The fixed broadband market in Ghana is severely limited, only […]
Read more

AbbVie challenges J&J with Skyrizi PsA submission, says GlobalData

In early April, AbbVie announced its submission to the US FDA for its selective interleukin (IL)-23 inhibitor, Skyrizi (risankizumab), for the indication of psoriatic arthritis (PsA). If approved, Skyrizi would be the second inhibitor available for the disease, however, Skyrizi is entering an increasingly crowded and competitive field with numerous existing branded agents and biosimilars […]
Read more

Investments into data analytics set to pick up pace as it remains a key insurance theme, says GlobalData

The COVID-19 pandemic hit investor confidence and halted business, which led to investments into big data declining, but it is a temporary decline and the theme remains critical to insurance, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Thematic Research: Big Data in insurance’, reveals that the value and volume of […]
Read more
1 … 56 57 58 59 60